Summary
🧪 Tissue Engineering
Fixed MSC Spheroids as Off-the-Shelf Immunomodulatory Therapeutics
Advanced Materials 2020 Research Team
Research Overview
MSC therapy is promising but limited by cell variability and short shelf life. This innovative study shows that chemically fixed MSC spheroids retain their immunomodulatory properties while becoming shelf-stable “off-the-shelf” therapeutics.
3D Petri Dish® enabled production of thousands of standardized spheroids for this work.
How 3D Petri Dish® Enabled This Research
Implications
Fixed MSC spheroids could democratize cell therapy by eliminating cold-chain requirements and batch-to-batch variability.
Key Discoveries
- Fixed MSC spheroids retain immunomodulatory secretome
- Shelf-stable at room temperature for extended periods
- Shape-versatile: can be molded into different geometries
- Effective in reducing inflammation in animal models